RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs ...
FITE is the smallest in assets under management, the least liquid in dollar volume, and the most diversified of these funds. Its expense ratio is average. It comes in fourth position for total return ...
Ramat Gan, Israel, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results